Our Lives: Vase Management president recounts how she built her own construction company
In this week's Our Lives, News 12's Gwen Edwards speaks with Vincencia Adusei, president of Vase Management, LLC who recounts how she built her construction company.
•
Apr 2, 2022, 6:43 PM
•
Updated 965 days ago
Share:
More Stories
2:50
Our Lives: Connecticut Women's Hall of Fame to add 3 new inductees
419ds ago3:23
Our Lives: Former police officer releases autobiography ‘Black and Blue in Bridgeport’
420ds ago3:20
Our Lives: Greater Waterbury Interfaith Ministries Hunger Walk
426ds ago3:19
Our Lives: Inclusive Leadership Impact Awards
427ds ago3:21
Our Lives: Stamford Board of Education member helps organize sessions for residents and local candidates to communicate
433ds ago3:13
Our Lives: CEO of Pinnacle Educational Center shares advice on applying to colleges
434ds ago2:50
Our Lives: Connecticut Women's Hall of Fame to add 3 new inductees
419ds ago3:23
Our Lives: Former police officer releases autobiography ‘Black and Blue in Bridgeport’
420ds ago3:20
Our Lives: Greater Waterbury Interfaith Ministries Hunger Walk
426ds ago3:19
Our Lives: Inclusive Leadership Impact Awards
427ds ago3:21
Our Lives: Stamford Board of Education member helps organize sessions for residents and local candidates to communicate
433ds ago3:13
Our Lives: CEO of Pinnacle Educational Center shares advice on applying to colleges
434ds agoIn this week's Our Lives, News 12's Gwen Edwards speaks with Vincencia Adusei, president of Vase Management, LLC who recounts how she built her construction company.
More from News 12
0:28
Waterbury man accused of killing woman, her infant son arrested by US marshals in Puerto Rico
2:02
Gusty winds and peeks of sunshine in Connecticut; tracking storm chances for Thanksgiving week
0:36
Police: 16-year-old fatally shot in New Haven; passing school bus struck by stray bullet
0:22
Police: Darien High School student questioned for concerning social media post
2:15
Tech advancements, new treatments fuel spike in lung cancer survival rates
0:17
